Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Int J Hyperthermia. 2010;26(5):514–521. doi: 10.3109/02656731003639364

Table I.

Pathological response by patient characteristics.

CR or PR No response
No. of patients N = 26 N = 17
Tumour size (median) (cm) 6 6
Stage
    IIA(T2N1M0, T3N0M0) 8 (31%) 5 (29%)
    IIIA(T0N2M0, T1N2M0, T2N2M0, T3N1M0, T3N2M0) 9 (35%) 6 (35%)
IIIB (T4Any NM0) 9 (35%) 6 (35%)
Inflammatory 9 (35%) 5 (29%)
ER+ and/or PR+ 21 (81%) 16 (94%)
Her2/neu+ 6 (23%) 5 (29%)